Like killing a chicken’: Trauma expert on mission to

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone
Like killing a chicken’: Trauma expert on mission to record ISIS horror stories

Abu Chiad boasted about beheading infidels, raping women and children and slaughtering in the name of Islam. Speaking from a prison in the city of Kirkuk, in northern Iraq, he told Dr. Jan Kizilhan that these acts would get him to heaven.

Kizilhan, 49, a German of Kurdish background, is a psychology professor and trauma expert who has worked with trauma victims in Rwanda and Kosovo. He went to Iraq with Michael Blume, minority affairs expert for the German state of Baden-Wurttemberg, to help the victims of ISIS. Their mission was to bring traumatized women and children back to Germany for treatment.

In a telephone interview, Blume said he eagerly took advantage of an opportunity to save a thousand lives.

Baden-Wurttemberg has authorized $107 million over three years for this humanitarian work in response to an appeal from the 100,000-member German-Yazidi community following the ISIS massacre two years ago of Yazidis in the Sinjar region of northern Iraq. The Yazidis are an ancient non-Muslim minority in Iraq. They’ve lived in the Sinjar region for centuries.

Chiad, a 26-year old Chechen, had moved his wife and three children to Raqqa, Syria, to join the fight to create an Islamic State across Syria and Iraq. He embraced the ethnic cleansing that was intended to rid the region of Christians, Jews, non-Sunni Muslims and Yazidis.

“I asked Abu Chiad how he could show love for his wife and children and murder people the same day,” Kizilhan said in a phone interview from Stuttgart.

He said Chiad showed no remorse as he spoke about making daily trips to a marketplace to behead people and rape Yazidi women, after which he would return home as a loving father and husband.

“Killing them was like killing a chicken,” Chiad told Kizilhan.

In Chiad’s mind, Kizilhan said, the victims were not human. He said ISIS killers and rapists rationalize their behavior by dehumanizing their victims, much as the Nazis justified their mass slaughter of Jews in the Holocaust. He has written a book, “The Psychology of ISIS,” in which he analyzes this savage behavior. It will be published in Germany in October.

Kizilhan had horrifying stories to tell about the 1,100 women and children, former ISIS captives, who are now being treated in Germany, most of them at a facility near Stuttgart in Baden-Wurttenberg.

Rinda, 10, and her mother were abducted on Aug. 3, 2014, when ISIS invaded the Sinjar region. They were taken to Raqqa. Rinda was sold eight times to ISIS fighters, who beat and raped her. Her parents’ fate is not known.

Yasmin, 16, who feared another rape, wanted to make herself undesirable, so she doused herself with gasoline and lit a match. Badly burned, she is in a German hospital facing more than 20 surgeries.

“Now she looks like a zombie, and children cry when they see her,” Kizilhan said. “It is so difficult to see what the fire did to her.”

Most of the 400,000 Yazidis who lived in Sinjar have been displaced, captured or killed. According to a United Nations report, 5,000 Yazidi civilians were murdered in 2014, and women and children were sold into slavery. Many of the abuse victims have committed suicide.

Duzen Tekkal, a German-Yazidi journalist, went to Iraq to make a documentary — “Hawar” — about the plight of the Yazidi people. She went because people told her: “You are a Yazidi and a journalist and must come here and tell the world our story.”

“I knew it was very dangerous,” Tekkal said in a phone interview. “But I knew I had to go there.”

Like Kizilhan, she has difficult stories to tell. She speaks of children who are no longer children. “In one case,” she said, “A 9-year-old said, ‘Take me to be raped, not my little sister, please don’t touch her, take me,’ So they took the 6-year-old down the mountain, and they raped her.”

Tekkal said that many of the children repressed their rapes as a defense mechanism. “One 12-year-old said she wasn’t raped. But she was pregnant.”

Tekkal praised the work Kizilhan is doing. “We need hundreds of Dr. Kizilhans to deal with all the wounds inflicted by ISIS,” she said.

Kizilhan said Rinda often asks how ISIS can do such terrible things, how people can be so evil.

“I ask the same question,” he said. “Why is humanity still so evil in the 21st century?”


Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 14

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading

Top 5 Most Recently Viewed Articles

You Call The Play Inc. (YCTP) Leads with Integrity in Betting

Updated Category News Views 154

Understanding You Call The Play Inc. (YCTP)'s Initiative In an important move for the sports betting landscape, You Call The Play Inc. (YCTP) has recently unveiled a national licensing plan and a groundbreaking measure called the Safe Bet Overlay™. This initiative is designed to foster trust and transparency within an industry that continues to grow rapidly across the...

Continue Reading
Cash for Houses Pro Earns Stellar Reputation with 5-Star Reviews

Updated Category News Views 167

Cash for Houses Pro Achieves 5-Star Reviews Cash for Houses Pro is celebrating their recent success in receiving numerous 5-star reviews on Google for their service known as 'Sell Your House Fast In Tampa FL For Cash'. This recognition reflects the team's dedication to providing homeowners with a seamless and stress-free home selling experience. About Cash for Houses Pro...

Continue Reading
Pfizer's Potential Transformation Following Starboard Investment

Updated Category News Views 77

Pfizer's Revised Price Target and Market Standing Recently, CFRA, a prominent financial research firm, elevated its price target for Pfizer Inc. (NYSE:PFE) from $30.00 to $31.00 per share. This adjustment comes while maintaining a 'Hold' rating on the stock, suggesting a careful observation of its market performance. The current price target reflects a valuation based on...

Continue Reading
Equinox Gold's Impressive Q2 Results Spark Stock Surge Today

Updated Category News Views 103

Equinox Gold Delivers Strong Quarterly Performance Equinox Gold Corp. EQX has seen its shares rise significantly following the release of its second-quarter financial results, which exceeded market expectations. Investors reacted favorably, driving the stock up on Thursday. Financial Highlights from the Quarter In the latest quarterly report, Equinox Gold announced...

Continue Reading
Investor Insights on Alexandria Real Estate Equities' Legal Challenges

Updated Category News Views 219

Understanding the Alexandria Real Estate Equities, Inc. Lawsuit Investors have an important opportunity arising from a lawsuit against Alexandria Real Estate Equities, Inc. (NYSE: ARE). A national shareholder rights litigation firm has initiated a class action alleging the Company has violated various securities laws. This situation has caught the attention of many...

Continue Reading